Title
T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell-Derived Experimental Glioblastomas
UMMS Affiliation
Department of Radiology
Publication Date
2016-06-01
Document Type
Response or Comment
Disciplines
Neoplasms | Neurology | Radiology
Abstract
We read with great interest the article by Arevalo-Perez et al, describing the potential value of T1-weighted dynamic contrast-enhanced MR imaging (DCE-MR imaging) as a biomarker for epidermal growth factor receptor variant III (EGFRvIII) mutation in patients with glioblastoma (GBM).
DOI of Published Version
10.3174/ajnr.A4774
Source
AJNR Am J Neuroradiol. 2016 Jun;37(6):E49-51. Mar 17. Link to article on publisher's site
Journal/Book/Conference Title
AJNR. American journal of neuroradiology
Related Resources
PubMed ID
26988813
Repository Citation
Politi LS, Brugnara G, Castellano A, Cadioli M, Altabella L, Peviani M, Mazzoleni S, Falini A, Galli R. (2016). T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell-Derived Experimental Glioblastomas. Radiology Publications. https://doi.org/10.3174/ajnr.A4774. Retrieved from https://escholarship.umassmed.edu/radiology_pubs/229